FDMT — 4D MOLECULAR THERAPEUTICS IN
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 167 SEC-registered investment managers reported holding FDMT (4D MOLECULAR THERAPEUTICS IN) in their latest 13F filings, with a combined reported value of $749.57M across 56.45M shares. That is +6.2% by share count (+2.50M shares) versus the previous quarter, while reported value moved +51.7%. Ownership is concentrated: the five largest holders account for 40.5% of reported value and the top ten for 61.8%.
Compared with the prior quarter, 33 opened new positions, 65 added to existing stakes, 38 trimmed, 23 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of 4D MOLECULAR THERAPEUTICS IN (FDMT) include Jupiter Topco LLC, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., ranked by reported 13F value among the 340 institutional holders on this page.
FDMT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 110 | 19.06M | $272.79M | +3.2% |
| Q2 2026 | 167 | 56.45M | $749.57M | +6.2% |
| Q1 2026 | 157 | 48.88M | $454.24M | -4.5% |
| Q4 2025 | 160 | 53.90M | $404.90M | +20.5% |
| Q3 2025 | 138 | 41.01M | $358.11M | -1.6% |
| Q2 2025 | 123 | 40.88M | $152.67M | -4.9% |
| Q1 2025 | 128 | 44.53M | $145.46M | +1.9% |
| Q4 2024 | 141 | 47.58M | $265.63M | -15.6% |
Over the 8 quarters shown, institutional share counts decreased 60% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+20.5%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.72M | $67.61M | 0.00% | Add | |
| 2.47M | $35.34M | 0.00% | Reduce | |
| 2.14M | $30.63M | 0.00% | Add | |
| 1.18M | $16.95M | 0.00% | Add | |
| 1.09M | $15.61M | 0.00% | Add | |
| 787.00K | $11.26M | 0.00% | Add | |
| 578.93K | $8.28M | 0.00% | Hold | |
| 546.09K | $7.81M | 0.00% | Reduce | |
| 411.79K | $5.89M | 0.01% | Reduce | |
| 393.03K | $5.69M | 0.00% | Reduce | |
| 390.87K | $5.59M | 0.00% | Reduce | |
| 311.94K | $4.46M | 0.00% | Add | |
| 305.93K | $4.38M | 0.01% | New | |
| 300.72K | $4.30M | 0.00% | Add | |
| 260.12K | $3.72M | 0.00% | Add | |
| 241.86K | $3.46M | 0.00% | Hold | |
| 179.87K | $2.57M | 0.00% | Add | |
| 179.15K | $2.56M | 1.36% | Reduce | |
| 176.68K | $2.53M | 0.00% | Reduce | |
| 152.58K | $2.18M | 0.00% | Hold | |
| 146.19K | $2.09M | 0.04% | Hold | |
| 127.97K | $1.83M | 0.00% | Add | |
| 118.13K | $1.69M | 0.00% | Reduce | |
| 106.95K | $1.53M | 0.57% | Reduce | |
| 105.00K | $1.50M | 0.32% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.75M | $76.47M | 0.03% | New | |
| 5.05M | $67.16M | 0.58% | Hold | |
| 4.55M | $60.46M | 0.00% | Add | |
| 4.26M | $56.64M | 0.02% | Add | |
| 3.25M | $43.21M | 2.51% | Reduce | |
| 2.88M | $38.29M | 0.98% | Hold | |
| 2.51M | $33.41M | 0.02% | New | |
| 2.25M | $29.91M | 0.04% | Add | |
| 2.23M | $29.63M | 4.70% | Add | |
| 2.10M | $27.92M | 0.00% | New | |
| 2.00M | $26.60M | 0.35% | Hold | |
| 1.13M | $15.01M | 0.00% | New | |
| 1.13M | $15.01M | 0.00% | Add | |
| 1.12M | $14.90M | 0.00% | Add | |
| 951.47K | $12.65M | 0.20% | Hold | |
| 948.18K | $12.61M | 1.29% | Add | |
| 730.86K | $9.72M | 0.00% | Add | |
| 710.94K | $9.46M | 0.00% | Hold | |
| 614.57K | $8.17M | 0.01% | Add | |
| 579.90K | $7.71M | 0.00% | Add | |
| 571.11K | $7.60M | 1.65% | New | |
| 562.93K | $7.49M | 0.00% | Add | |
| 507.80K | $6.75M | 4.71% | Add | |
| 503.07K | $6.69M | 0.00% | Reduce | |
| 503.02K | $6.69M | 0.00% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.25M | $48.87M | 0.02% | Add | |
| 5.05M | $47.01M | 0.50% | Reduce | |
| 4.21M | $39.15M | 0.01% | Reduce | |
| 4.15M | $38.59M | 0.00% | Add | |
| 3.65M | $33.99M | 2.75% | Hold | |
| 2.88M | $26.81M | 0.85% | Reduce | |
| 2.71M | $25.21M | 0.00% | Add | |
| 2.00M | $18.62M | 0.37% | Add | |
| 1.61M | $14.94M | 0.02% | Add | |
| 1.43M | $13.33M | 0.02% | Reduce | |
| 1.30M | $12.13M | 2.95% | New | |
| 1.07M | $9.92M | 0.00% | Add | |
| 974.17K | $9.07M | 0.00% | Add | |
| 951.47K | $8.86M | 0.20% | Hold | |
| 708.04K | $6.59M | 0.00% | Add | |
| 578.26K | $5.38M | 0.01% | Add | |
| 561.80K | $5.23M | 0.00% | Add | |
| 555.83K | $5.17M | 0.00% | New | |
| 522.58K | $4.87M | 0.50% | Add | |
| 522.82K | $4.86M | 0.00% | Add | |
| 475.74K | $4.43M | 0.04% | Hold | |
| 380.42K | $3.58M | 2.26% | New | |
| 415.65K | $3.56M | 0.00% | Add | |
| 345.41K | $3.22M | 0.00% | Reduce | |
| 342.03K | $3.18M | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.65M | $42.40M | 0.43% | Add | |
| 4.64M | $34.73M | 0.02% | Add | |
| 4.63M | $34.72M | 1.17% | Hold | |
| 4.30M | $32.27M | 0.01% | Add | |
| 4.06M | $30.49M | 0.00% | Add | |
| 3.65M | $27.38M | 2.13% | Add | |
| 3.09M | $23.20M | 0.00% | Add | |
| 2.69M | $20.17M | 0.00% | Add | |
| 1.94M | $14.52M | 0.18% | Add | |
| 1.61M | $12.07M | 0.02% | Add | |
| 1.54M | $11.55M | 0.04% | New | |
| 1.24M | $9.26M | 0.01% | Add | |
| 1.01M | $7.59M | 0.00% | Add | |
| 951.47K | $7.14M | 0.14% | New | |
| 832.59K | $6.24M | 0.00% | Add | |
| 704.21K | $5.28M | 0.00% | Add | |
| 672.70K | $5.05M | 0.00% | Reduce | |
| 512.90K | $3.85M | 0.01% | Add | |
| 503.43K | $3.78M | 0.36% | Add | |
| 485.39K | $3.64M | 0.08% | Reduce | |
| 477.50K | $3.58M | 0.00% | Add | |
| 475.74K | $3.57M | 0.02% | New | |
| 475.74K | $3.57M | 0.04% | New | |
| 353.39K | $2.65M | 0.00% | Add | |
| 353.39K | $2.65M | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.63M | $40.23M | 1.63% | Hold | |
| 4.56M | $39.65M | 0.49% | Hold | |
| 4.13M | $35.88M | 0.01% | Reduce | |
| 3.87M | $33.62M | 0.00% | Reduce | |
| 2.58M | $22.38M | 0.00% | Reduce | |
| 2.00M | $17.38M | 1.12% | Hold | |
| 1.75M | $15.24M | 0.01% | Hold | |
| 1.59M | $13.86M | 0.02% | Reduce | |
| 1.15M | $9.99M | 0.02% | Reduce | |
| 1.15M | $9.99M | 0.00% | Reduce | |
| 1.10M | $9.52M | 0.14% | Add | |
| 913.52K | $7.94M | 0.00% | Reduce | |
| 903.77K | $7.85M | 0.00% | Reduce | |
| 835.91K | $7.26M | 0.00% | Reduce | |
| 819.27K | $7.12M | 0.00% | Add | |
| 663.66K | $5.77M | 0.01% | Add | |
| 549.70K | $4.78M | 0.01% | Reduce | |
| 543.33K | $4.72M | 0.00% | Add | |
| 513.51K | $4.46M | 0.00% | Reduce | |
| 504.12K | $4.38M | 0.08% | Reduce | |
| 471.27K | $4.10M | 0.00% | Add | |
| 335.59K | $2.92M | 0.00% | Add | |
| 322.08K | $2.80M | 2.50% | Add | |
| 313.19K | $2.72M | 0.00% | Add | |
| 305.86K | $2.66M | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.63M | $17.17M | 0.61% | Add | |
| 4.56M | $16.93M | 0.28% | Hold | |
| 4.16M | $15.43M | 0.01% | Hold | |
| 4.01M | $14.88M | 0.00% | Reduce | |
| 2.74M | $10.15M | 0.00% | Reduce | |
| 2.00M | $7.42M | 0.52% | Add | |
| 1.75M | $6.51M | 0.00% | Reduce | |
| 1.67M | $6.19M | 0.01% | Add | |
| 1.48M | $5.50M | 0.01% | Reduce | |
| 1.48M | $5.50M | 0.00% | Reduce | |
| 961.96K | $3.57M | 0.00% | Reduce | |
| 924.68K | $3.43M | 0.00% | Reduce | |
| 918.53K | $3.41M | 0.00% | Reduce | |
| 888.02K | $3.29M | 0.00% | Hold | |
| 743.40K | $2.76M | 0.01% | Add | |
| 648.83K | $2.41M | 0.01% | Hold | |
| 531.16K | $1.97M | 0.00% | Add | |
| 514.61K | $1.91M | 0.03% | Reduce | |
| 455.47K | $1.69M | 0.00% | Add | |
| 328.98K | $1.22M | 0.00% | Reduce | |
| 318.54K | $1.18M | 1.18% | Add | |
| 30.00K | $1.17M | 0.00% | Hold | |
| 300.00K | $1.11M | 0.02% | Hold | |
| 295.04K | $1.09M | 0.00% | Add | |
| 295.04K | $1.09M | 0.00% | Add |
New Positions (Q2 2026)
- Jupiter Topco LLC 5.75M sh · $76.47M
- T. Rowe Price Investment Management, Inc. 2.51M sh · $33.41M
- VANGUARD CAPITAL MANAGEMENT LLC 2.10M sh · $27.92M
- GEODE CAPITAL MANAGEMENT, LLC 1.13M sh · $15.01M
- DIADEMA PARTNERS LP 571.11K sh · $7.60M
- Catalio Capital Management, LP 471.25K sh · $6.27M
- Sixth Street Partners Management Company, L.P. 339.27K sh · $4.51M
- Brevan Howard Capital Management LP 176.85K sh · $2.35M
- Persistent Asset Partners Ltd 145.59K sh · $1.94M
- Greenland Capital Management LP 72.26K sh · $961.02K
- Caption Management, LLC 70.00K sh · $931.00K
- SG Americas Securities, LLC 66.44K sh · $884.00K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 5.25M sh · $48.87M
- STATE STREET CORP sold 2.71M sh · $25.21M
- Peapod Lane Capital LLC sold 241.48K sh · $2.21M
- Exome Asset Management LLC sold 130.56K sh · $1.22M
- ADAR1 Capital Management, LLC sold 116.71K sh · $1.09M
- Simplify Asset Management Inc. sold 70.43K sh · $655.70K
- Principia Wealth Advisory, LLC sold 53.67K sh · $499.65K
- Quadrature Capital Ltd sold 32.52K sh · $302.80K
- Virtu Financial LLC sold 26.37K sh · $245.00K
- Y-Intercept (Hong Kong) Ltd sold 25.42K sh · $236.66K
- EntryPoint Capital, LLC sold 21.60K sh · $201.12K
- ExodusPoint Capital Management, LP sold 15.53K sh · $144.57K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 4.72M | 4.55M | 4.15M | 4.06M | 3.87M | 4.01M | 4.55M | 4.92M | 4.87M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.47M | — | 2.71M | 2.69M | 903.77K | 961.96K | 1.03M | 1.11M | 2.12M | 2.08M | 2.18M | 1.52M | 1.72M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.14M | 2.10M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.18M | 1.13M | 1.07M | 1.01M | 913.52K | 918.53K | 963.27K | 1.01M | 1.04M | 1.06M | 872.66K | 778.16K | 741.66K | 689.78K | 577.92K | 561.74K | 528.94K | 492.82K | 478.62K | 482.44K |
| Morgan Stanley | 1.09M | 503.02K | 345.41K | 672.70K | 835.91K | 924.68K | 1.78M | 1.86M | 1.70M | 1.46M | 1.55M | 1.57M | 1.47M | 1.57M | 1.74M | 1.46M | 2.02M | 313.04K | 420.04K | 434.08K |
| DIMENSIONAL FUND ADVISORS LP | 787.00K | 730.86K | 522.82K | 294.84K | 58.01K | 55.94K | 74.57K | 131.97K | 208.81K | 532.74K | 748.99K | 694.89K | 670.60K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 578.93K | 579.90K | 555.83K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deutsche Bank AG | 546.09K | 710.94K | 708.04K | 704.21K | 543.33K | 226.94K | 236.16K | 241.85K | 802.64K | 124.34K | 121.86K | 486.99K | 15.57K | 676.15K | 80.27K | 74.97K | 73.32K | 13.29K | 15.52K | 17.28K |
| Renaissance Technologies | 411.79K | 614.57K | 578.26K | 512.90K | 313.19K | 116.55K | 19.55K | — | — | — | 69.83K | — | — | — | 13.80K | 128.10K | 69.10K | 259.60K | 69.10K | 44.80K |
| JPMorgan Chase & Co | 393.03K | 402.14K | 415.65K | 279.50K | 513.51K | 888.02K | 886.71K | 820.07K | 315.98K | 345.77K | 16.60K | 3.80K | 585.45K | 457.21K | 417.32K | 439.97K | 453.11K | 478.76K | 367.55K | 283.39K |
| Nuveen, LLC | 390.87K | 503.07K | 561.80K | 158.77K | 93.92K | 100.70K | 150.31K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 311.94K | 128.32K | 70.10K | 65.65K | 65.57K | 62.07K | 7.87K | 2.04K | 4.10K | 1.02M | 968.88K | 3.64K | 2.76K | 2.83K | 2.69K | 26.90K | 288.20K | 700.45K | 1.09M | 1.14M |
| HRT FINANCIAL LP | 305.93K | — | — | — | — | 43.90K | 50.40K | 83.42K | — | — | — | 9.99K | 26.02K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 300.72K | 276.24K | 269.30K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Invesco Ltd | 260.12K | 150.38K | 310.68K | 153.14K | 126.58K | 140.32K | 117.77K | 28.16K | 27.43K | 27.45K | 27.67K | 14.08K | 17.48K | 215.58K | — | 196.20K | 10.55K | 10.65K | 10.74K | 10.98K |
| RAYMOND JAMES FINANCIAL INC | 241.86K | 242.35K | 266.15K | 477.50K | 471.27K | 455.47K | 294.38K | 112.90K | — | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 179.87K | 23.82K | 25.44K | 170.64K | 93.83K | 111.78K | 97.04K | 105.25K | 114.85K | 47.65K | 47.82K | 108.71K | 73.94K | — | — | — | — | — | — | — |
| Propel Bio Management, LLC | 179.15K | 252.65K | 380.42K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 176.68K | 222.42K | 1.43M | 1.61M | 1.59M | 1.67M | 1.25M | 3.76K | — | — | 27 | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 152.58K | 152.34K | 133.61K | 136.74K | 141.72K | 141.10K | 134.85K | 145.94K | 146.41K | 169.41K | 131.40K | 144.94K | 135.71K | 116.28K | 108.45K | 109.91K | 107.22K | 97.81K | 101.32K | 100.19K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold FDMT?
As of 2026-Q2, 167 institutional funds reported holding FDMT (4D MOLECULAR THERAPEUTICS IN) in SEC 13F filings, with a combined reported value of $749.57M.
How many shares of FDMT do institutions own?
13F filers reported 56.45M shares of FDMT, worth $749.57M in aggregate at the end of 2026-Q2.
Is institutional ownership of FDMT rising or falling?
Share counts moved +6.2% versus the prior quarter — accumulation.
Who are the top institutional holders of FDMT?
The largest 13F holders are Jupiter Topco LLC, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP, Viking Global Investors; the top 25 are ranked at the top of this page.
Who are the major shareholders of 4D MOLECULAR THERAPEUTICS IN?
The major shareholders of 4D MOLECULAR THERAPEUTICS IN (FDMT) by reported 13F value are Jupiter Topco LLC, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP, Viking Global Investors, among 340 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.